DEVELOPING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR QUANTITATIVE CHARACTERIZATION OF EXOGENOUSLY ADMINISTERED T CELLS.

被引：0
|
作者：
Khot, A. [1 ]
Shah, D. K. [1 ]
机构：
[1] SUNY Buffalo, Buffalo, NY USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PBPK-007
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [21] Physiologically-based pharmacokinetic (PBPK) model to describe the disposition of pyronaridine
    Diep, John K.
    Lingerfelt, Mary A.
    Ekins, Sean
    Rao, Gauri G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S34 - S34
  • [22] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR DESETHYLAMIODARONE
    HOU, ZY
    BALTER, NJ
    WOOSLEY, RL
    SCHWARTZ, SL
    CIRCULATION, 1990, 82 (04) : 196 - 196
  • [23] Physiologically-based pharmacokinetic model for 2,4-dinitrophenol
    Lyndsey F. Meyer
    Pooja M. Rajadhyaksha
    Dhaval K. Shah
    Journal of Pharmacokinetics and Pharmacodynamics, 2022, 49 : 325 - 336
  • [24] Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats
    Ai, Jing
    Gao, Yunfeng
    Yang, Fan
    Zhao, Zhen
    Dong, Jin
    Wang, Jing
    Fu, Shiyi
    Ma, Ying
    Gu, Xu
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [25] Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia
    Lee, Joomi
    Kim, Min-Gul
    Jeong, Hyeon-Cheol
    Shin, Kwang-Hee
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (01) : 33 - 44
  • [26] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE INHIBITION OF ACETYLCHOLINESTERASE BY ORGANOPHOSPHATE ESTERS
    GEARHART, JM
    JEPSON, GW
    CLEWELL, HJ
    ANDERSEN, ME
    CONOLLY, RB
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 : 51 - 60
  • [27] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY
    Kyler, K.
    Shakhnovich, V.
    Selvarangan, R.
    Sasidharan, A.
    Chan, S.
    Artz, N.
    Williams, V.
    Friesen, C.
    Pearce, R.
    Gaedigk, A.
    Leeder, J.
    Galetin, A.
    Johnson, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S106 - S107
  • [28] Physiologically-based pharmacokinetic model for 2,4-dinitrophenol
    Meyer, Lyndsey F.
    Rajadhyaksha, Pooja M.
    Shah, Dhaval K.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2022, 49 (03) : 325 - 336
  • [29] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ABSORPTION OF ORAL PARACETAMOL IN MAN
    CLEMENTS, JA
    NIMMO, WS
    HEADING, RC
    PRESCOTT, LF
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 : P60 - P60
  • [30] PREDICTION OF ANTICHOLINESTERASE ACTIVITY AND URINARY METABOLITES OF ISOFENPHOS - USE OF A PERCUTANEOUS PHYSIOLOGICALLY-BASED PHARMACOKINETIC PHYSIOLOGICALLY-BASED PHARMACODYNAMIC MODEL
    KNAAK, JB
    ALBAYATI, MA
    RAABE, OG
    BLANCATO, JN
    BIOMARKERS OF HUMAN EXPOSURE TO PESTICIDES, 1994, 542 : 284 - 300
12345